S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Laser breakthrough could send stock soaring 2,467% (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Laser breakthrough could send stock soaring 2,467% (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Laser breakthrough could send stock soaring 2,467% (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Laser breakthrough could send stock soaring 2,467% (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Laser breakthrough could send stock soaring 2,467% (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Laser breakthrough could send stock soaring 2,467% (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Laser breakthrough could send stock soaring 2,467% (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Laser breakthrough could send stock soaring 2,467% (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Laser breakthrough could send stock soaring 2,467% (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Laser breakthrough could send stock soaring 2,467% (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Laser breakthrough could send stock soaring 2,467% (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Laser breakthrough could send stock soaring 2,467% (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
OTCMKTS:TAIPY

Taisho Pharmaceutical (TAIPY) Stock Forecast, Price & News

$10.68
+0.25 (+2.40%)
(As of 09/29/2023 ET)
Compare
Today's Range
$10.37
$10.68
50-Day Range
$9.50
$10.98
52-Week Range
$8.51
$11.19
Volume
1,923 shs
Average Volume
7,322 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TAIPY stock logo

About Taisho Pharmaceutical (OTCMKTS:TAIPY) Stock

Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The company offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the Colac series of laxative products; the Naron series and other products for antipyretic analgesics; the Preser series of hemorrhoid treatment products; Hapacol, Efferalgan, Dafalgan, and Tempra for antipyretic analgesics; Counterpain topical anti-inflammatory analgesics; Vitacilina, a dermatological treatment product; and VICKS, a cough suppressant throat lozenges and medicated drops. Further it provides Clarith, a macrolide antibiotic; Bonviva, a bisphosphonate osteoporosis agent; Lusefi, a type 2 diabetes mellitus agent; and LOQOA, a transdermal anti-inflammatory analgesic. The company also offers raw materials for pharmaceuticals and quasi-drugs; and supplies health foods and skin care products, as well as engages in real estate leasing, management, possession, and operation. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is based in Tokyo, Japan.

TAIPY Price History

TAIPY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive TAIPY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Taisho Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TAIPY
Fax
N/A
Employees
8,784
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Akira Uehara (Age 82)
    CEO & Representative Director
    Comp: $766.14k
  • Mr. Shigeru Uehara
    Exec. VP & Director
  • Shinichi Tanaka
    Gen. Mang. of Corp. Communications
  • Mr. Ken Uehara
    MD & Exec. Director
  • Mr. Tetsu Watanabe
    Exec. Director
  • Mr. Jun Kuroda (Age 65)
    Exec. VP & Director













TAIPY Stock - Frequently Asked Questions

How have TAIPY shares performed in 2023?

Taisho Pharmaceutical's stock was trading at $11.08 on January 1st, 2023. Since then, TAIPY shares have decreased by 3.6% and is now trading at $10.68.
View the best growth stocks for 2023 here
.

Are investors shorting Taisho Pharmaceutical?

Taisho Pharmaceutical saw a increase in short interest in September. As of September 15th, there was short interest totaling 400 shares, an increase of 33.3% from the August 31st total of 300 shares. Based on an average daily trading volume, of 6,700 shares, the short-interest ratio is currently 0.1 days.
View Taisho Pharmaceutical's Short Interest
.

What is Taisho Pharmaceutical's stock symbol?

Taisho Pharmaceutical trades on the OTCMKTS under the ticker symbol "TAIPY."

How do I buy shares of Taisho Pharmaceutical?

Shares of TAIPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Taisho Pharmaceutical's stock price today?

One share of TAIPY stock can currently be purchased for approximately $10.68.

How many employees does Taisho Pharmaceutical have?

The company employs 8,784 workers across the globe.

How can I contact Taisho Pharmaceutical?

Taisho Pharmaceutical's mailing address is 3-24-1 Takada, Toshima-ku, Tokyo 170-8655, Japan. The official website for the company is www.taisho-holdings.co.jp. The company can be reached via phone at (133) 985-2020.

This page (OTCMKTS:TAIPY) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -